UCSF vs. brain diseases: Labs, patients meet at new $200M neuroscience center

(San Francisco Business Times subscription required.)
UCSF’s plan for blending bench research and treating real-life patients is coming together as labs and new science recruits move into a $200 million, 237,000-square-foot neuroscience center.
The product of a unique private-public partnership, the five-story Mission Bay structure eventually will house 600 University of California, San Francisco, employees, including 86 investigators and their labs. That will place them within steps of patients with Alzheimer’s disease, multiple sclerosis and other brain and nervous system disorders as they try to develop drugs, devices and diagnostic tests.
“We hope to make remarkable progress,” said Nobel laureate Dr. Stanley Prusiner, a UCSF neurology professor, director of the Institute for Neurodegenerative Diseases and a driving force behind the building.